<DOC>
	<DOCNO>NCT00800553</DOCNO>
	<brief_summary>The purpose study characterize anti-cholinesterase inhibitor ( AChE-I ) donepezil modulates brain region involve visual short-term memory , episodic memory inhibitory efficiency follow 24 hour total sleep deprivation use fMRI additional marker drug effect .</brief_summary>
	<brief_title>fMRI-behavioral Study Cholinergic Augmentation With Donepezil Healthy Sleep Deprived Adults</brief_title>
	<detailed_description>Short-term total sleep deprivation ( SD ) result cognitive impairment ( Durmer Dinges , 2005 ) contribute industrial catastrophe , transportation accident , medical error ( Mitler et al. , 1988 ; Dinges , 1995 ; Barger et al. , 2006 ; Philip Akerstedt , 2006 ) . This motivate use pharmacological countermeasure , widely use caffeine ( Bonnet et al. , 2005 ) . Functional image study sleep-deprived person could provide information concern neural substrate associate SD-induced cognitive decline addition , provide functional assay assess drug effect . However , despite grow number functional imaging study involve SD ( Chee Chuah , 2008 ) , neuropharmacological study context rare ( Thomas Kwong , 2006 ) . Impairment attention sleep-deprived person ( Lim Dinges , 2008 ) important cognitive deficit affect 'higher ' cognitive operation , example , visual short-term memory ( VSTM ) ( Chee Chuah , 2007 ) . VSTM use service many high cognitive operation capacity limit ( Luck Vogel , 1997 ; Cowan , 2000 ) neuroimaging correlate ( Linden et al. , 2003 ; Majerus et al. , 2007 ; Mitchell Cusack , 2007 ) . SD-induced decline VSTM capacity show originate depress visual attention visual processing ( Chee Chuah , 2007 ) . This inferred observe state-dependent , load-independent , attenuation parieto-occipital activation elicit two visual task memory perceptual load independently parametrically vary . Critically , load-independent manner SD affect parieto-occipital activation across task signify something fundamental memory depress . We reason decline attention/visual processing might arise reduce noradrenergic cholinergic drive , give neurotransmitter underlie maintenance wakefulness ( Everitt Robbins , 1997 ; Steriade McCarley , 2005 ) well visuospatial attention ( Everitt Robbins , 1997 ; Phillips et al. , 2000 ) . Increasing cholinergic transmission may improve visual work memory increase selectivity perceptual processing visual cortex ( Furey et al. , 2000a ) . Other experiment visual memory suggest behavioral benefit may associate increase extrastriate ( Furey et al. , 2000a ; Lawrence et al. , 2002 ) superior parietal ( Mentis et al. , 2001 ) region . Conversely , cholinergic blockade use scopolamine may impair orient response involve parietal region ( Davidson Marrocco , 2000 ) . Of relevance present study , concentration cholinergic effect parieto-occipital region coincides locus state effect several functional imaging study short term memory ( Habeck et al. , 2004 ; Chee Chuah , 2007 ; Lim et al. , 2007 ) sleep-deprived person . Collectively , finding lead u hypothesize SD-induced deficit visual processing/attention might benefit cholinergic augmentation . We anticipate neural correlate performance modulation could track observe task-related parieto-occipital activation . To evaluate hypothesis , conduct double-blind , placebo-controlled , cross-over functional imaging study characterize effect donepezil healthy young adult . In within-subjects design , volunteer scan four time , twice follow normal night 's sleep twice 24 hour total SD .</detailed_description>
	<mesh_term>Sleep Deprivation</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 . The subject able read understand Subject Information Sheet comply protocol requirement , instruction protocolstated restriction . 2 . Prior screening procedure , subject physician must sign studyspecific Informed Consent Form . No studyrelated procedure may perform physician obtain write informed consent subject . 3 . The subject 21 year 35 year age . 4 . The subject BMI 18.5 kg/m2 32 kg/m2 body weight â‰¥ 50 kg . 5 . The subject righthanded . 6 . The subject resting pulse &gt; 40 bpm &lt; 90 bpm ( normal range ) . The subject rest systolic blood pressure 91 mmHg 140 mmHg ( supine normal range ) rest diastolic blood pressure 51 mmHg 90 mmHg ( supine normal range ) . 7 . The subject , opinion investigator , good health basis prestudy physical examination , medical history , vital sign , electrocardiogram ( ECG ) , result blood chemistry , haematology , serology test , urinalysis . A subject clinical abnormality laboratory parameter outside reference range age group may include Investigator considers find introduce additional risk factor interfere study procedure . 8 . The subject habitual good sleeping habit : sleeping average 6.5 9 hour night past month . 9 . Have regular sleeping hour whereby sleep later 1 rise 9 day . 10 . Have history excessive daytime sleepiness insomnia . 11 . Score great 22 MorningnessEveningness scale [ Horne Ostberg , 1976 ] . 12 . If female , subject must use double barrier method contraception ( 2 separate method contraception ) Screening final discharge study . Oral contraceptive allow . 1 . The subject take prohibited medication within 1 week ( 14 day drug potential enzyme inducer ) within 5 halflives prior first dose medication ingest , whichever long ) prior first dosing , unless opinion investigator sponsor , medication interfere study procedure compromise safety . Prohibited medication prescribe medication overthecounter ( OTC ) medication , include highdose vitamin dietary supplement , herbal medicine know interfere metabolic CYP pathway , ( e.g . St. John 's Wort ) cognitive function ( e.g . ginko ) . Paracetamol mild analgesia permit . 2 . The subject significant history drug alcohol abuse , define alcohol intake great 21 unit per week history drug abuse within last 6 month , history substance abuse deem significant investigator . A unit alcohol define 250 mL lager/beer , 100 mL Wine , 25 mL spirit . 3 . The subject orthostatic blood pressure reduction &gt; 20 mmHg ( base difference systolic blood pressure supine stand 1 minute ) . 4 . The subject expose 3 new chemical entity ( NCEs ) within 12 month prior first dose day , participate trial drug within 84 day start study , participate trial NCE within 112 day start study . 5 . History presence hypersensitivity study drug drug class ( hyoscine , atropine , donepezil ) history severe drug allergy hypersensitivity , opinion physician responsible , contraindicate participation . 6 . The subject serious illness , liver renal insufficiency , cardiovascular , pulmonary , gastrointestinal , endocrine , neurological , infectious , neoplastic , metabolic disturbance condition know interfere absorption , distribution , metabolism excretion drug . 7 . The subject history presence peptic ulcer disease , cardiac arrhythmia , cardiac conduction abnormality , asthma obstructive pulmonary disease . 8 . The subject history presence psychiatric neurological illness , obstructive sleep apnea , narcolepsy periodic leg movement ascertain questionnaire . 9 . If participation study result subject donate 1500 mL blood previous 12 month participation study would result donation blood excess 500 mL within 56 day period . 10 . The subject smoke 10 cigarette per day use nicotine contain product equivalent 10 cigarette per day ( example , snuff , nicotine patch , nicotine chew gum , mock cigarette , inhaler ) able refrain use nicotine containing product complete study period . 11 . The subject test positive screening baseline drug abuse ( opiate , methadone , cocaine , amphetamine , barbiturate , benzodiazepine , cannabinoids ) . 12 . Caffeine intake great 5 drink per day average . 13 . Presence glaucoma raise intraocular pressure base medical history . 14 . Has abnormality acoustic function . 15 . The presence cardiac pacemaker electronic device ferromagnetic metal foreign body . 16 . The volunteer report previous mark feeling claustrophobia enclose environment . 17 . Abnormal anatomical MRI define radiologist prestudy screen e.g . tumour , evidence stroke , localize white matter lesion , excessive atrophy ( local global ) , aneurysms , vascular malformation . 18 . Subjects complete neuropsychological test battery despite undergone training session . 19 . The subject 's QTc ( use Bazett 's correction ) equal great 430 m ( Screening ) read printout ECG produce ECG equipment evaluate investigator . 20 . The subject , opinion investigator , unlikely comply clinical study protocol unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>sleep deprivation</keyword>
	<keyword>fMRI</keyword>
	<keyword>double blind crossover study</keyword>
</DOC>